These images, created for the biotechnology company TolerRx, were used in an IPO and PowerPoint presentations. TolerRx specializes in the discovery and development of therapies that induce, maintain, or remove immunological tolerance and reprogram the immune system in order to treat patients with immune-related diseases. The challenge in this project was how to best visually demonstrate the workings of their TRX1 monoclonal antibody, while keeping the subject matter clear and understandable for both investors and scientists. When clients need to have processes depicted clearly and accurately, I ask questions, create sketches to demonstrate possible approaches and become an integral part of the conceptualizing team. The result is high quality images that educate and impact the indended audiences.